Thomas NJ, Myall NJ, Sun F, Patil T, et al. In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?" J Thorac Oncol 2022;17:e12-e14.
PMID: 35074229